Jazz Pharmaceuticals (JAZZ) Profit After Tax Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.64 Bn | 12.79 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.19% |
| Dec 31, 2025 | 8.81% |
| Sep 30, 2025 | 11.14% |
| Jun 30, 2025 | -52.54% |
| Mar 31, 2025 | 10.14% |
| Dec 31, 2024 | 20.90% |
| Sep 30, 2024 | 16.03% |
| Jun 30, 2024 | -8.44% |
| Mar 31, 2024 | -16.78% |
| Dec 31, 2023 | -10.00% |
| Sep 30, 2023 | -0.34% |
| Jun 30, 2023 | 2.50% |
| Mar 31, 2023 | 8.58% |
| Dec 31, 2022 | -24.88% |
| Sep 30, 2022 | -18.22% |
| Jun 30, 2022 | -19.97% |
| Mar 31, 2022 | -54.72% |
| Dec 31, 2021 | -18.16% |
| Sep 30, 2021 | -20.95% |
| Jun 30, 2021 | -38.91% |
| Mar 31, 2021 | 9.95% |
| Dec 31, 2020 | 10.02% |
| Sep 30, 2020 | 11.00% |
| Jun 30, 2020 | 5.43% |
| Mar 31, 2020 | -33.45% |
| Dec 31, 2019 | -1.94% |
| Sep 30, 2019 | 31.75% |
| Jun 30, 2019 | 43.09% |
| Mar 31, 2019 | 23.90% |
| Dec 31, 2018 | 23.60% |
| Sep 30, 2018 | 14.64% |
| Jun 30, 2018 | 16.96% |
| Mar 31, 2018 | 1.15% |
| Dec 31, 2017 | 2.97% |
| Sep 30, 2017 | 13.59% |
| Jun 30, 2017 | 27.69% |
| Mar 31, 2017 | 23.40% |
| Dec 31, 2016 | 25.51% |
| Sep 30, 2016 | 22.56% |
| Jun 30, 2016 | 28.09% |
| Mar 31, 2016 | 28.28% |
| Dec 31, 2015 | 17.17% |
| Sep 30, 2015 | 22.05% |
| Jun 30, 2015 | 21.56% |